Big pharma stung in HHS fraud report

Half of the $4 billion in fraudulent health care claims recouped by the government last year came from big pharma. An HHS report cites fraud by drug and device makers, with Allergan's $600 million fine and settlement for off-label Botox marketing topping the list. Allergan is followed by Novartis Pharmaceuticals, with $422.5 million in fines; AstraZeneca, $520 million; Forest Laboratories and Forest Pharmaceuticals, $313 million; and Teva, $100 million. HHS release | Report (PDF)

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.